Alembic Ltd. (BSE: 506235) is a Vadodara, Gujarat-based company in the Real Estate Development industry. With a market capitalisation of ₹2,500 Cr, it ranks #1,136 by market cap among the 6,137 Indian listed companies on FinBizNet, and #34 of 218 in Real Estate Development. At ₹86.73 (as of 25 Oct 2026), the share price is 26.3% below its 52-week high of ₹117.72 and 23.1% above its 52-week low of ₹70.46. The share price is down 11.4% over one year and down 1.4% over three months.
| Current Price | ₹86.73 |
|---|---|
| Market Cap | ₹2,500 Cr |
| BSE Code | 506235 |
| Sector | Real Estate > Real Estate Operating Companies > Real Estate Management and Development |
| Sub-Industry | Real Estate Development |
| P/E Ratio | 7.7 |
| Return on Equity | 13.27% |
| Return on Assets | 1.91% |
| 52-Week Range | ₹70.46 – ₹117.72 |
| 1-Year Price Change | -11.4% |
| 3-Month Price Change | -1.4% |
| Beta (1Y) | 0.71 |
| Dividend Yield | 2.52% |
| Headquarters | Vadodara, Gujarat |
| Website | www.alembiclimited.com |
| Revenue | ₹49 Cr |
|---|---|
| Net Profit | ₹16 Cr |
| Net Margin | 32.2% |
| EPS (Basic) | ₹2.53 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Alembic Limited engages in real estate business in India and internationally. It operates through Active Pharmaceutical Ingredient (API) and Real Estate segments. The company constructs residential and commercial real estate projects; provides project management and marketing consultancy services; and leases commercial properties. It also manufactures and markets fermentation and chemistry based active pharmaceutical ingredient; and engages in research and development activities. In addition, it is involved in power generation through co-generation plants and wind power sources. The company serves individuals, entrepreneurs, corporates, business houses, HNIs, NRIs, and pharmaceutical companies. The company was incorporated in 1907 and is based in Vadodara, India. Alembic Limited is a subsidiary of Nirayu Pvt. Ltd.
1. Active Pharmaceutical Ingredient (API)-This segment offers active pharmaceuticals ingredients. 2. Real Estate-This segment engages in the real estate business. 3. Unallocable Assets-0 4. Segment Adjustment-0
1. Active Pharmaceutical Ingredient (API)-19.4% 2. Real Estate-80.6%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| DLF Ltd | ₹1,67,084 Cr | 37.8 | 10.03% | ₹1,261 Cr | -14.6% |
| Macrotech Developers Ltd | ₹1,05,777 Cr | 30.1 | 15.71% | ₹4,997 Cr | -19.4% |
| Prestige Estates Projects Ltd. | ₹64,265 Cr | 52.9 | 8.00% | ₹2,675 Cr | -17.9% |
| Oberoi Realty Limited | ₹61,921 Cr | 24.4 | 14.91% | ₹1,671 Cr | -4.4% |
| Godrej Properties Limited | ₹48,296 Cr | 25.8 | 9.97% | ₹1,935 Cr | -32.1% |
| Brigade Enterprises Ltd. | ₹18,768 Cr | 21.6 | 10.79% | ₹1,116 Cr | -24.6% |
| Anant Raj Ltd | ₹18,383 Cr | 31.3 | 11.13% | ₹631 Cr | -27.3% |
| Sobha Limited | ₹12,710 Cr | 64.9 | 4.17% | ₹967 Cr | -22.1% |
| Alembic Ltd. | ₹2,500 Cr | 7.7 | 13.27% | ₹49 Cr | -11.4% |
Listed by market capitalisation. Ratios are shown for context only.
Alembic Ltd. is trading at ₹86.73, with a market capitalisation of ₹2,500 Cr.
Alembic Ltd. operates in the Real Estate > Real Estate Operating Companies > Real Estate Management and Development space (Real Estate Development).
Alembic Ltd. has a P/E of 7.7 and a return on equity of 13.27%.
Alembic Ltd. is listed on the BSE under the scrip code 506235.
Alembic Ltd.'s share price is down 11.4% over one year and down 1.4% over three months. Its 52-week range is ₹70.46 to ₹117.72.
In Q1 FY27, Alembic Ltd. reported revenue of ₹49 Cr and net profit of ₹16 Cr, with basic EPS of ₹2.53 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.